Bluejay Diagnostics Provides Q2 2026 Fiscal and Business Update

What Happened
On August 13, 2026, Bluejay Diagnostics, Inc. (BJDX) furnished a Regulation FD disclosure (Item 7.01) by issuing a press release that provides its 2026 second quarter fiscal and business update. The release followed the company’s August 12, 2026 filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026. The press release is furnished as Exhibit 99.1 to the Form 8-K.

Key Details

• Bluejay filed its Form 10-Q for the quarter ended June 30, 2026 on August 12, 2026.
• On August 13, 2026 the company issued a press release with its Q2 2026 fiscal and business update; that release is furnished as Exhibit 99.1.
• The disclosure was furnished under Regulation FD (Item 7.01), indicating broad public dissemination of the update.

Why It Matters
This 8-K signals that Bluejay has publicly shared its second-quarter update alongside its Form 10-Q. Retail investors should read the Form 10-Q and the furnished press release for the company’s detailed quarterly results, cash position, and operational developments. Because the update was furnished under Regulation FD, the information was broadly disclosed to the market rather than reserved for selected parties.